Johnson & Johnson (NYSE:JNJ) is reportedly in talks to acquire Actelion Ltd (SWX:ATLN). Johnson & Johnson and Actelion have asked Switzerland's takeover board about the viability of a complicated takeover deal, the U.S. healthcare company is discussing with the Swiss biotech firm, as reported by Tages-Anzeiger.